Taken together, these results suggested that sLex moieties are likely involved in mediating the binding interactions of breast cancer cells to E-selectin and that breast cancer cell transendothelial migration is positively correlated to the binding activity of the exE-selectin/Fc recombinant to tumor cells. The gene discussed is SELE; the disease is breast carcinoma.